Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

All Cancer Sites (All Stages^), 2016-2020

White Non-Hispanic, Both Sexes, All Ages

Sorted by Count
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count ascending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) § 1 461.9 (461.6, 462.3) N/A 1,273,624 stable stable trend -0.2 (-0.5, 0.2)
California 7 438.9 (437.7, 440.2) 36 (35, 38) 99,664 falling falling trend -1.2 (-1.9, -0.9)
Florida 6 484.7 (483.2, 486.2) 7 (5, 8) 97,952 stable stable trend -0.1 (-0.4, 0.1)
New York 7 507.2 (505.5, 508.8) 3 (3, 3) 79,819 falling falling trend -0.4 (-1.7, -0.2)
Texas 7 445.3 (443.8, 446.8) 33 (32, 34) 73,472 stable stable trend 0.5 (0.0, 1.5)
Pennsylvania 6 469.6 (468.0, 471.3) 19 (15, 22) 68,077 falling falling trend -0.6 (-1.8, -0.4)
Ohio 6 468.9 (467.2, 470.7) 20 (15, 23) 59,624 rising rising trend 0.7 (0.3, 1.4)
Illinois 7 478.9 (477.0, 480.8) 9 (8, 14) 52,791 stable stable trend 0.1 (-0.8, 1.2)
Michigan 6 436.9 (435.1, 438.8) 38 (36, 39) 46,221 falling falling trend -1.0 (-1.1, -0.8)
North Carolina 6 471.5 (469.5, 473.6) 16 (13, 21) 44,385 falling falling trend -0.3 (-0.6, -0.2)
New Jersey 7 516.1 (513.6, 518.5) 1 (1, 2) 38,261 falling falling trend -0.3 (-0.5, -0.1)
Georgia 7 480.7 (478.4, 483.0) 8 (7, 12) 36,219 stable stable trend 0.0 (-0.1, 0.1)
Massachusetts 7 461.3 (459.0, 463.7) 25 (23, 28) 32,936 stable stable trend -0.2 (-0.8, 0.9)
Tennessee 6 461.1 (458.8, 463.4) 26 (24, 28) 31,918 falling falling trend -0.4 (-0.7, -0.2)
Washington 5 441.7 (439.4, 443.9) 35 (33, 37) 31,855 falling falling trend -1.2 (-2.0, -1.0)
Wisconsin 6 466.3 (463.9, 468.8) 23 (18, 25) 31,228 stable stable trend -0.1 (-0.2, 0.1)
Virginia 6 416.9 (414.8, 419.1) 41 (41, 43) 30,264 stable stable trend -0.1 (-0.7, 1.2)
Missouri 6 453.1 (450.7, 455.4) 29 (27, 32) 30,164 falling falling trend -0.5 (-1.2, -0.3)
Minnesota 6 476.9 (474.3, 479.4) 12 (8, 15) 29,123 rising rising trend 1.0 (0.3, 2.1)
Arizona 6 398.5 (396.2, 400.9) 45 (44, 46) 26,007 falling falling trend -0.6 (-0.8, -0.5)
Kentucky 7 512.5 (509.6, 515.4) 2 (1, 2) 25,516 stable stable trend -0.5 (-1.0, 0.0)
Maryland 6 478.2 (475.2, 481.2) 11 (8, 15) 21,190 stable stable trend 0.0 (-0.3, 0.8)
South Carolina 6 438.8 (436.0, 441.6) 37 (34, 39) 20,930 falling falling trend -1.9 (-2.7, -1.2)
Alabama 6 442.1 (439.3, 445.0) 34 (33, 37) 20,104 falling falling trend -0.7 (-1.2, -0.3)
Colorado 6 397.2 (394.7, 399.8) 46 (45, 46) 20,019 stable stable trend 0.2 (-0.4, 0.6)
Oregon 6 425.7 (422.9, 428.4) 40 (40, 41) 19,859 falling falling trend -0.7 (-0.8, -0.5)
Iowa 7 490.7 (487.4, 494.0) 4 (4, 6) 18,154 rising rising trend 1.0 (0.2, 1.8)
Louisiana 7 486.8 (483.5, 490.1) 5 (4, 8) 18,031 rising rising trend 0.7 (0.2, 1.3)
Connecticut 7 467.8 (464.5, 471.1) 22 (15, 24) 17,268 falling falling trend -0.6 (-0.8, -0.2)
Oklahoma 6 434.1 (431.0, 437.2) 39 (37, 39) 16,228 stable stable trend 0.0 (-0.4, 1.1)
Arkansas 6 470.8 (467.3, 474.4) 17 (13, 23) 14,572 rising rising trend 1.2 (0.3, 2.0)
Kansas 6 452.2 (448.7, 455.8) 30 (27, 32) 13,502 falling falling trend -0.5 (-1.1, -0.3)
West Virginia 6 486.4 (482.3, 490.5) 6 (4, 9) 11,690 stable stable trend -0.2 (-0.4, 0.1)
Mississippi 6 468.8 (464.7, 472.8) 21 (14, 24) 11,118 stable stable trend 0.3 (0.0, 1.2)
Utah 7 404.5 (400.9, 408.2) 44 (43, 45) 9,951 falling falling trend -0.4 (-0.6, -0.2)
Nebraska 6 462.9 (458.5, 467.3) 24 (19, 28) 9,333 stable stable trend 0.1 (-0.9, 0.9)
Maine 6 474.6 (470.0, 479.2) 14 (8, 21) 9,041 stable stable trend -0.2 (-0.6, 0.9)
New Hampshire 6 478.6 (473.8, 483.4) 10 (6, 16) 8,405 falling falling trend -0.5 (-0.7, -0.3)
Idaho 7 449.6 (445.2, 454.1) 32 (28, 34) 8,393 stable stable trend 0.4 (-0.2, 1.4)
Montana 6 451.4 (446.0, 456.8) 31 (27, 33) 5,956 stable stable trend -0.5 (-1.7, 0.4)
Rhode Island 6 473.1 (467.2, 479.1) 15 (8, 23) 5,487 falling falling trend -0.6 (-0.8, -0.4)
New Mexico 7 386.7 (381.6, 391.9) 47 (47, 47) 5,320 stable stable trend -0.5 (-1.7, 1.3)
Delaware 6 470.5 (463.9, 477.1) 18 (9, 26) 4,563 falling falling trend -1.0 (-2.5, -0.6)
South Dakota 6 459.5 (453.2, 465.8) 27 (20, 31) 4,526 stable stable trend 0.1 (-0.2, 0.9)
Vermont 6 456.4 (449.6, 463.2) 28 (23, 32) 3,828 stable stable trend 0.3 (-0.6, 1.7)
Wyoming 6 410.9 (403.7, 418.3) 43 (41, 44) 2,678 falling falling trend -0.7 (-1.1, -0.3)
Hawaii 7 476.2 (466.5, 486.2) 13 (4, 25) 2,270 falling falling trend -0.4 (-0.6, -0.3)
Alaska 6 414.2 (406.1, 422.4) 42 (40, 44) 2,244 falling falling trend -1.4 (-1.7, -1.0)
District of Columbia 6 357.4 (346.5, 368.6) 48 (48, 48) 857 falling falling trend -1.9 (-2.8, -0.9)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
North Dakota 6
§§§
N/A
§§§
§§§
§§§
Puerto Rico 6
¶¶¶
N/A
¶¶¶
¶¶¶
¶¶¶
Notes:
Created by statecancerprofiles.cancer.gov on 03/28/2024 1:51 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

¶¶¶ Data for Puerto Rico is only available for All Races (includes Hispanics). For more information see data not available.
§§, §§§ Data not available for this combination of geography, statistic, age, and race/ethnicity.
Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
7 Source: SEER November 2022 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2022 data.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top